title: Case 34: acute leukemia in a patient with a previous history of breast cancer.
abstract: A 56-year-old woman presented with acute myeloid leukemia 3 years after presenting with carcinoma of the breast. Detailed investigations led to a precise diagnosis.
authors.affiliation: Department of Haematology, St Mary's Hospital, London, UK.
authors.forename: Ian H
authors.initials: IH
authors.lastname: Gabriel
authors.forename: Saad H
authors.initials: SH
authors.lastname: Abdalla
authors.forename: Sarah
authors.initials: S
authors.lastname: Ryley
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Bain
mesh_terms: D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000473:pathology; D003520:Cyclophosphamide / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D005434:Flow Cytometry; D015321:Gene Rearrangement; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D016130:Immunophenotyping; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000139:chemically induced* / Q000188:drug therapy / Q000235:genetics; D008875:Middle Aged; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics; D059005:Topoisomerase II Inhibitors
chemical_list: D000970:Antineoplastic Agents; C497422:KMT2A protein, human; D059005:Topoisomerase II Inhibitors; D051788:Myeloid-Lymphoid Leukemia Protein; D004317:Doxorubicin; D003520:Cyclophosphamide; D011495:Histone-Lysine N-Methyltransferase